ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

NCI-Approved Clinical Trials

May 28, 2004

NCAB Oks Organ Systems Plan, Criteria For Starting, Ending Working Groups

October 7, 1988

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976